Background Terminal restriction fragment length polymorphism (T-RFLP) analysis is a
powerful tool to assess the diversity of a microbial community. In this study, we performed T …

Background Recent studies suggest that gastrointestinal (GI) microbes play a part in the
pathogenesis of Crohn's disease (CD). Methods Fecal samples were collected from 16 …

Prior studies reported inconsistent results on the altered gut microbial composition in
patients with Crohn's disease (CD), likely under the influences of many confounding factors …

Background A custom phylogenetic microarray composed of small subunit ribosomal RNA
probes, representing≈ 500 bacterial species from the human and animal gut, was …

Inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn's
disease (CD), is characterized by relapse and remission alternately. It remains a great …

Background Abnormalities have been described in the fecal microbiota of patients with IBD,
but it is not known whether they are specific for inflammatory bowel disease (IBD) or to some …

Background Inflammatory bowel disease (IBD) is a multifactorial chronic inflammatory
disease resulting from dysregulation of the mucosal immune response and gut microbiota …

Abstract Background and Aims: Gut microbiota is involved in many physiological functions
and its imbalance is associated with several diseases, particularly with inflammatory bowel …

Gut microbiota shows host-specific diversity and temporal stability and significantly
contributes to maintenance of a healthy gut. However, in inflammatory bowel disease, this …

Background Gut microbiota dysbiosis is associated with the occurrence and development of
Crohn disease (CD). Currently, infliximab (IFX) is used more and more to treat CD; however …